Drug Description in Trials / DrugBank / KEGG DRUG
Search results
No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
---|---|---|---|---|---|---|
1 | ALL subjects will receive maraviroc 300MG orally twice A DAY FOR 6 weeks | - | - | - | - | [1] 84 84 💬
|
2 | Maraviroc | [1] Maraviroc Maraviroc (Maravirocum) | [1] Maraviroc
Maraviroc
(Maraviroc, MARAVIROC) 💬
| [1] CCR5 CCR5 💬
| [11] Chemokine signaling pathway Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Toxoplasmosis, Viral carcinogenesis, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬 | [1] 46 46 💬
|